12 results on '"Hoermann, Rudolf"'
Search Results
2. Triiodothyronine secretion in early thyroid failure: The adaptive response of central feedforward control.
- Author
-
Hoermann R, Pekker MJ, Midgley JEM, Larisch R, and Dietrich JW
- Subjects
- Adult, Aged, Autoantibodies immunology, Computer Simulation, Female, Humans, Hypothalamo-Hypophyseal System metabolism, Hypothyroidism immunology, Iodide Peroxidase immunology, Male, Middle Aged, Models, Theoretical, Pituitary Gland metabolism, Thyroiditis, Autoimmune immunology, Thyrotropin-Releasing Hormone metabolism, Feedback, Physiological, Hypothyroidism metabolism, Thyroid Gland metabolism, Thyroiditis, Autoimmune metabolism, Thyrotropin metabolism, Thyroxine metabolism, Triiodothyronine metabolism
- Abstract
Background: Defined by thyroid-pituitary feedback control, clinical diagnosis of hypothyroidism and hyperthyroidism has become synonymous with TSH measurement. We combined in silico analysis and in vivo data to explore the central influences on thyroidal T3 production., Materials & Methods: A system of five coupled first-order nonlinear parameterised ordinary differential equations (ODEs) is used to model the feedback control of TSH and TRH by thyroid hormones together with the feedforward control of thyroidal T3 secretion and enzymatic T4-T3 conversion. Dependencies of the stable equilibrium solutions of this ODE system, that is the homeostasis of the underlying physiological process, on the system parameters were investigated whether they accounted for clinical observations., Results: During the modelled transition to hypothyroidism, central control imposed an increasing influence in maintaining serum FT3 levels, compared to peripheral conversion efficiency. Numerical continuation analysis revealed dependencies of T3 production on different elements of TSH feedforward control. While T4-T3 conversion provided the main T3 source in euthyroidism, this was overtaken by increasing glandular T3 secretion when thyroid reserve declined. The computational results were in good agreement with data from untreated patients with autoimmune thyroiditis., Conclusions: Dependencies revealed in the expression of control differ in thyroid health and disease, using a physiologically based mathematical model of combined feedback-feedforward control of the hypothalamic-pituitary-thyroid regulation. Strong T3-protective mechanisms of the control system emerge with declining thyroid function, when glandular T3 secretion becomes increasingly influential over conversion efficiency. This has wide-ranging implications for the utility of TSH in clinical decision-making., (© 2020 Stichting European Society for Clinical Investigation Journal Foundation.)
- Published
- 2020
- Full Text
- View/download PDF
3. Symptomatic Relief is Related to Serum Free Triiodothyronine Concentrations during Follow-up in Levothyroxine-Treated Patients with Differentiated Thyroid Cancer.
- Author
-
Larisch R, Midgley JEM, Dietrich JW, and Hoermann R
- Subjects
- Adult, Female, Follow-Up Studies, Humans, Hyperthyroidism blood, Male, Middle Aged, Retrospective Studies, Thyroidectomy, Hypothyroidism blood, Hypothyroidism drug therapy, Quality of Life, Thyroid Neoplasms surgery, Thyroxine administration & dosage, Triiodothyronine blood
- Abstract
Aim: Patients on levothyroxine-treatment frequently have complaints although TSH is within the reference range. Moreover, FT3 is often low in these patients. The clinical significance of this disequilibrium is studied here., Patients, Methods: We conducted a retrospective longitudinal study including 319 patients with differentiated thyroid carcinoma on LT4-medication (1.8 [1.6,2.1] µg/kg body weight). Patients were followed at 2309 visits for at median 63 [46,81] months. Association of reported complaints during follow-up with changes in thyroid parameters were analysed using a generalised linear mixed model accounting for within-variability and intra-subject correlations., Results: 26% of patients expressed hypothyroid and 9.7% hyperthyroid complaints at any one visit, rates per visit being 6.5% and 2%, respectively. During follow-up, median changes in spans were as follows, LT4-dose 0.49 [IQR 0.29,0.72] µg/kg, FT3 1.77 [1.25,2.32] pmol/l, FT4 9.80 [6.70,12.8] pmol/l and TSH 1.25 [0.42,2.36] mIU/l. While rates of both hypothyroid or hyperthyroid symptoms were significantly related to all three thyroid parameters, the relationship of hypothyroid symptoms with FT3 extended to a below reference TSH range. Hypothyroid symptom relief was associated with both a T4 dose giving TSH-suppression below the lower reference limit and FT3 elevated further into the upper half of its reference range. In multivariable analysis, relationships between complaints and FT3 concentrations remained significant after adjusting for gender, age and BMI., Conclusion: Residual hypothyroid complaints in LT4-treated patients are specifically related to low FT3 concentrations. This supports an important role of FT3 for clinical decision making on dose adequacy, particularly in symptomatic athyreotic patients., Competing Interests: JWD received funding and personal fees by Sanofi-Henning, Hexal AG and Pfizer, and is co-owner of the intellectual property rights for the patent “System and Method for Deriving Parameters for Homeostatic Feedback Control of an Individual” (Singapore Institute for Clinical Sciences, Biomedical Sciences Institutes, Application Number 201208940-5, WIPO number WO/2014/088516). All other authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported., (© Georg Thieme Verlag KG Stuttgart · New York.)
- Published
- 2018
- Full Text
- View/download PDF
4. Derivation of a multivariate reference range for pituitary thyrotropin and thyroid hormones: diagnostic efficiency compared with conventional single-reference method.
- Author
-
Hoermann R, Larisch R, Dietrich JW, and Midgley JE
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Prospective Studies, Reference Values, Sensitivity and Specificity, Thyroid Function Tests, Young Adult, Thyrotropin blood, Thyroxine blood, Triiodothyronine blood
- Abstract
Unlabelled: : Although pituitary thyrotropin (TSH) and thyroid hormones are physiologically interrelated, interpretation of measurements is conventionally done separately. Classification of subclinical thyroid dysfunction depends by definition solely on an abnormal TSH. This study examines a composite multivariate approach to disease classification., Methods: Bivariate and trivariate reference limits were derived from a thyroid-healthy control group (n=271) and applied to a clinically diverse sample (n=820) from a prospective study, comparing their diagnostic efficiency with the conventional method., Results: The following 95% reference limits were derived from the control group: (i) separate reference intervals for TSH, free thyroxine (FT4) and free triiodothyronine (FT3); (ii) bivariate composite reference limits for the logarithmically transformed TSH and FT4, and (iii) trivariate composite reference limits including all three parameters. A multivariate approach converts the "rectangular" or "cuboid" graphical representations of the independent parameters into an ellipse or ellipsoid. When applying these reference limits to the clinical sample, thyroid dysfunctions were classified differently, compared with the separate method, in 6.3 or 12% of all cases by the bivariate or trivariate method respectively. Of the established dysfunctions according to the separate intervals, 26% were reclassified to "euthyroid" by using the bivariate limit. Discrepancies from the laboratory-evaluated reference range were less pronounced., Conclusions: Frequent divergencies between composite multivariate reference limits and a combination of separate univariate reference intervals suggest that statistical analytic techniques may heavily influence thyroid disease classification. This challenges the validity of the conjoined roles of TSH currently employed as both a sensitive screening test and a reliable classification tool for thyroid disease., (© 2016 European Society of Endocrinology.)
- Published
- 2016
- Full Text
- View/download PDF
5. Of rats and men: thyroid homeostasis in rodents and human beings.
- Author
-
Dietrich JW, Midgley JE, Larisch R, and Hoermann R
- Subjects
- Animals, Humans, Hormone Replacement Therapy methods, Hypothyroidism drug therapy, Thyroxine therapeutic use, Triiodothyronine therapeutic use
- Published
- 2015
- Full Text
- View/download PDF
6. Homeostatic equilibria between free thyroid hormones and pituitary thyrotropin are modulated by various influences including age, body mass index and treatment.
- Author
-
Hoermann R, Midgley JE, Giacobino A, Eckl WA, Wahl HG, Dietrich JW, and Larisch R
- Subjects
- Adult, Age Factors, Aged, Body Mass Index, Female, Homeostasis, Humans, Hypothyroidism drug therapy, Male, Middle Aged, Prospective Studies, Thyroid Diseases metabolism, Thyroxine therapeutic use, Hormone Replacement Therapy, Hyperthyroidism metabolism, Hypothyroidism metabolism, Thyroid Gland metabolism, Thyrotropin metabolism, Thyroxine metabolism, Triiodothyronine metabolism
- Abstract
Objective: We examined the interrelationships of pituitary thyrotropin (TSH) with circulating thyroid hormones to determine whether they were expressed either invariably or conditionally and distinctively related to influences such as levothyroxine (L-T4) treatment., Design and Methods: This prospective study employing 1912 consecutive patients analyses the interacting equilibria of TSH and free triiodothyronine (FT3) and free thyroxine (FT4) in the circulation., Results: The complex interrelations between FT3, FT4 and TSH were modulated by age, body mass, thyroid volume, antibody status and L-T4 treatment. By group comparison and confirmation by more individual TSH-related regression, FT3 levels were significantly lower in L-T4-treated vs untreated nonhypothyroid autoimmune thyroiditis (median 4·6 vs 4·9 pm, P < 0·001), despite lower TSH (1·49 vs 2·93 mU/l, P < 0·001) and higher FT4 levels (16·8 vs 13·8 pm, P < 0·001) in the treated group. Compared with disease-free controls, the FT3-TSH relationship was significantly displaced in treated patients with carcinoma, with median TSH of 0·21 vs 1·63 (P < 0·001) at a comparable FT3 of 5·0 pm in the groups. Disparities were reflected by calculated deiodinase activity and remained significant even after accounting for confounding influences in a multivariable model., Conclusions: TSH, FT4 and FT3 each have their individual, but also interlocking roles to play in defining the overall patterns of thyroidal expression, regulation and metabolic activity. Equilibria typical of the healthy state are not invariant, but profoundly altered, for example, by L-T4 treatment. Consequently, this suggests the revisitation of strategies for treatment optimization., (© 2014 John Wiley & Sons Ltd.)
- Published
- 2014
- Full Text
- View/download PDF
7. Modeling Supportive and Disruptive Mechanisms of FT3 Homeostasis: Supplementary Information
- Author
-
Hoermann, Rudolf, Pekker, Mark J, Midgley, John E M, and Dietrich, Johannes W
- Subjects
hypothalamic pituitary thyroid axis ,triiodothyronine ,homeostasis ,mathematical model - Abstract
Wepresent a mechanistic mathematicalmodelwhichextendsthe concept of HPT axis regulation beyond TSH and FT4 to integrate the biologically more active sister hormone FT3 and mechanisms of FT3 homeostasis. Disruption of homeostatic mechanisms leads to disease. The mathematical model consists of a system of four coupled first-order parametrized nonlinear ordinary differential equations (ODEs), which were developed to account for the interdependencies between the four hormones TRH, TSH, FT4 and FT3 in the network of the hypothalamic-pituitary-thyroid (HPT) axis regulation. While TRH and TSH feed forward to the pituitary and thyroid, respectively, FT4 and FT3 feed back to both the pituitary and hypothalamus.FT4 is converted to its biologically more active sister hormone FT3 through a partly TSH-dependent multi-enzyme process. Themodel evaluatesdisease-defining mechanisms, frequently conflated in population statistics, structural parameters and individualized homeostatic outcomes and targets..This is particularly important, given theadaptive expression of balancein thecomplex regulatory network ofthe HPT axis regulation, which tend to move in a non-linear way and are otherwise difficult to predict.
- Published
- 2022
- Full Text
- View/download PDF
8. Minimal HPT Axis Model: Supplementary Information
- Author
-
Hoermann, Rudolf, Pekker, Mark J, Midgley, John E M, Larisch, Rolf, and W, Dietrich Johannes
- Subjects
Quantitative Biology::Neurons and Cognition ,triiodothyronine ,homeostasis ,allostasis ,adaptation ,endocrine regulation ,mathematical model ,hypothalamic-pituitary-thyroid axis - Abstract
A minimal mathematical model, in the form of a parametrized nonlinear dynamical system of 4 ODEs, is formulated as a proof-of-concept to elucidate principles of hypothalamic-pituitary-thyroid (HPT) axis regulation. The model allows uncovering mechanisms for the homeostasis of the key biologically active hormone free triiodothyronine (FT3)., {"references":["Hoermann et al. 2020 doi:10.1111/eci.13192"]}
- Published
- 2022
- Full Text
- View/download PDF
9. Principles of Endocrine Regulation: Reconciling Tensions Between Robustness in Performance and Adaptation to Change.
- Author
-
Hoermann, Rudolf, Pekker, Mark J., Midgley, John E. M., Larisch, Rolf, and Dietrich, Johannes W.
- Subjects
NONLINEAR dynamical systems ,TELECOMMUNICATION systems ,HYPOTHALAMIC-pituitary-thyroid axis - Abstract
Endocrine regulation in the hypothalamic-pituitary-thyroid (HPT) axis is orchestrated by physiological circuits which integrate multiple internal and external influences. Essentially, it provides either of the two responses to overt biological challenges: to defend the homeostatic range of a target hormone or adapt it to changing environmental conditions. Under certain conditions, such flexibility may exceed the capability of a simple feedback control loop, rather requiring more intricate networks of communication between the system's components. A new minimal mathematical model, in the form of a parametrized nonlinear dynamical system, is here formulated as a proof-of-concept to elucidate the principles of the HPT axis regulation. In particular, it allows uncovering mechanisms for the homeostasis of the key biologically active hormone free triiodothyronine (FT3). One mechanism supports the preservation of FT3 homeostasis, whilst the other is responsible for the adaptation of the homeostatic state to a new level. Together these allow optimum resilience in stressful situations. Preservation of FT3 homeostasis, despite changes in FT4 and TSH levels, is found to be an achievable system goal by joining elements of top-down and bottom-up regulation in a cascade of targeted feedforward and feedback loops. Simultaneously, the model accounts for the combination of properties regarded as essential to endocrine regulation, namely sensitivity, the anticipation of an adverse event, robustness, and adaptation. The model therefore offers fundamental theoretical insights into the effective system control of the HPT axis. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
10. Lessons from Randomised Clinical Trials for Triiodothyronine Treatment of Hypothyroidism: Have They Achieved Their Objectives?
- Author
-
Hoermann, Rudolf, Midgley, John E. M., Larisch, Rolf, and Dietrich, Johannes W.
- Subjects
- *
TRIIODOTHYRONINE , *COMBINATION drug therapy , *HOMEOSTASIS , *HYPOTHYROIDISM , *QUALITY of life , *THYROID hormones , *DECISION making in clinical medicine , *RANDOMIZED controlled trials , *PATIENT selection , *PSYCHOLOGY , *THERAPEUTICS - Abstract
Randomised controlled trials are deemed to be the strongest class of evidence in evidence-based medicine. Failure of trials to prove superiority of T3/T4 combination therapy over standard LT4 monotherapy has greatly influenced guidelines, while not resolving the ongoing debate. Novel studies have recently produced more evidence from the examination of homeostatic equilibria in humans and experimental treatment protocols in animals. This has exacerbated a serious disagreement with evidence from the clinical trials. We contrasted the weight of statistical evidence against strong physiological counterarguments. Revisiting this controversy, we identify areas of improvement for trial design related to validation and sensitivity of QoL instruments, patient selection, statistical power, collider stratification bias, and response heterogeneity to treatment. Given the high individuality expressed by thyroid hormones, their interrelationships, and shifted comfort zones, the response to LT4 treatment produces a statistical amalgamation bias (Simpson’s paradox), which has a key influence on interpretation. In addition to drug efficacy, as tested by RCTs, efficiency in clinical practice and safety profiles requires reevaluation. Accordingly, results from RCTs remain ambiguous and should therefore not prevail over physiologically based counterarguments. In giving more weight to other forms of valid evidence which contradict key assumptions of historic trials, current treatment options should remain open and rely on personalised biochemical treatment targets. Optimal treatment choices should be guided by strict requirements of organizations such as the FDA, demanding treatment effects to be estimated under actual conditions of use. Various improvements in design and analysis are recommended for future randomised controlled T3/T4 combination trials. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
11. Is pituitary TSH an adequate measure of thyroid hormone-controlled homoeostasis during thyroxine treatment?
- Author
-
Hoermann, Rudolf, Midgley, John E. M, Larisch, Rolf, and Dietrich, Johannes W.
- Subjects
- *
THYROTROPIN , *TRIIODOTHYRONINE , *HYPERTHYROIDISM , *HYPOTHYROIDISM , *THYROXINE - Abstract
Objective: In recognition of its primary role in pituitary-thyroid feedback, TSH determination has become a key parameter for clinical decision-making. This study examines the value of TSH as a measure of thyroid hormone homoeostasis under thyroxine (T4) therapy. Design and methods: We have examined the interrelationships between free triiodothyronine (FT3), free T4 (FT4) and pituitary TSH by means of i) a retrospective analysis of a large clinical sample comprising 1994 patients either untreated or on varying doses of L-T4 and ii) independent mathematical simulation applying a model of thyroid homoeostasis, together with a sensitivity analysis. Results: Over a euthyroid to mildly hyperthyroid functional range, we found markedly different correlation slopes of log TSH vs FT3 and FT4 between untreated patients and L-T4 groups. Total deiodinase activity (GD) was positively correlated with TSH in untreated subjects. However, GD was significantly altered and the correlation was lost under increasing L-T4 doses. Ninety-five per cent confidence intervals for FT3 and FT4, when assessed in defined TSH concentration bands, differed significantly for L-T4-treated compared with untreated patients. Higher doses were often needed to restore FT3 levels within its reference range. Sensitivity analysis revealed the influence of various structural parameters on pituitary TSH secretion including an important role of pituitary deiodinase type 2. Conclusion: The data reveal disjoints between FT4-TSH feedback and T3 production that persist even when sufficient T4 apparently restores euthyroidism. T4 treatment displays a compensatory adaptation but does not completely re-enact normal euthyroid physiology. This invites a study of the clinical consequences of this disparity. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
12. Time for a reassessment of the treatment of hypothyroidism.
- Author
-
Midgley, John E. M., Toft, Anthony D., Larisch, Rolf, Dietrich, Johannes W., and Hoermann, Rudolf
- Subjects
HYPOTHYROIDISM diagnosis ,HYPOTHYROIDISM ,THYROTROPIN ,THYROXINE ,TRIIODOTHYRONINE - Abstract
Background: In the treatment for hypothyroidism, a historically symptom-orientated approach has given way to reliance on a single biochemical parameter, thyroid stimulating hormone (TSH). Main body: The historical developments and motivation leading to that decision and its potential implications are explored from pathophysiological, clinical and statistical viewpoints. An increasing frequency of hypothyroid-like complaints is noted in patients in the wake of this directional shift, together with relaxation of treatment targets. Recent prospective and retrospective studies suggested a changing pattern in patient complaints associated with recent guideline-led low-dose policies. A resulting dramatic rise has ensued in patients, expressing in various ways dissatisfaction with the standard treatment. Contributing factors may include raised problem awareness, overlap of thyroid-related complaints with numerous non-specific symptoms, and apparent deficiencies in the diagnostic process itself. Assuming that maintaining TSH anywhere within its broad reference limits may achieve a satisfactory outcome is challenged. The interrelationship between TSH, free thyroxine (FT4) and free triiodothyronine (FT3) is patient specific and highly individual. Population-based statistical analysis is therefore subject to amalgamation problems (Simpson's paradox, collider stratification bias). This invalidates group-averaged and range-bound approaches, rather demanding a subject-related statistical approach. Randomised clinical trial (RCT) outcomes may be equally distorted by intra-class clustering. Analytical distinction between an averaged versus typical outcome becomes clinically relevant, because doctors and patients are more interested in the latter. It follows that population-based diagnostic cut-offs for TSH may not be an appropriate treatment target. Studies relating TSH and thyroid hormone concentrations to adverse effects such as osteoporosis and atrial fibrillation invite similar caveats, as measuring TSH within the euthyroid range cannot substitute for FT4 and FT3 concentrations in the risk assessment. Direct markers of thyroid tissue effects and thyroid-specific quality of life instruments are required, but need methodological improvement. Conclusion: It appears that we are witnessing a consequential historic shift in the treatment of thyroid disease, driven by over-reliance on a single laboratory parameter TSH. The focus on biochemistry rather than patient symptom relief should be re-assessed. A joint consideration together with a more personalized approach may be required to address the recent surge in patient complaint rates. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.